Senior Group Leader at Josep Carreras Institute.
Chromatin; Nucleal metabolism; Leukemia; MDS; Drug Targets; Histone variants.
Posting about the lab and the wider scientific community.
More info about us here: www.buschbecklab.org
Marcus Buschbeck and Lab
Loading...
Please RT: Opportunity to join us as technician!
We are looking for a technician to support us in our projects in MPN and other myeloid malignancies using epigenomics on primary samples and PDX mouse models.
Where: @carrerasijc.bsky.social
When: Anytime.
What: 👉https://sl1nk.com/0ekf3z6
Check out the new profile page of the lab on LinkedIN!
We will post news about:
- Changes in the team composition
- Opportunities
- Where to meet us
- Preprints, publications and theses
Indeed, we have been growing. Find out more here:
www.linkedin.com/company/busc...
MEET THE LAB!
Paula, Jeannine, Marina and Marcus are in Finland attending the @EHA_Hematology Research Conference #EHAReCon2026 "From cradle to grave: normal and malignant hematopoiesis in young and aged settings".
For our presentations, come and check out Poster 44 & Poster 68!
Great opportunity for Senescence aficionados to share results and network in Spain's most beautiful university town!
Last opportunity to join the NUCLEAR network as PhD student!
Last opportunity to join the NUCLEAR network as PhD student in a Biotech environment!
Or visit the lab's official website.
buschbecklab.org
Buschbeck Lab | 50 followers on LinkedIn. We combine basic and applied research in chromatin and metabolism in myeloid malignancies. | We combine basic research and applied research. In our basic rese...
As 2025 comes to a close, my university (Dalhousie U in Halifax, Canada) is recruiting faculty, including outstanding early career researchers, and Canada Research Chairs. Applications are due January 19 2026 (was just notified today!). Please repost.
OFERTA DE EMPLEO (por favor difundir):
Ofrecemos un contrato predoctoral de 4 años asociado a nuestro proyecto PID2024-157249OB-I00. El objetivo del proyecto es evaluar un nuevo mecanismo patológico según el cual la competición entre promotores puede llegar a ocasionar enfermedades congénitas
👇
Marcus Buschbeck and Lab
Marcus Buschbeck and Lab
Marcus Buschbeck and Lab
Ten days left to apply to be a @crick.ac.uk Early Career Group Leader
Closing date 27th November
www.crick.ac.uk/careers-stud...
Marcus Buschbeck and Lab
Marcus Buschbeck and Lab
Backed by the Government of Canada’s $1.7 billion Global Impact+ Research Talent Initiative, Dalhousie University is undertaking one of the most ambitious research-leader recruitment efforts in its hi...
Two opportunities across two continents to connect with the cellular senescence community in 2026 🌍!
Excited to be part of the organizing team for the @yicsac.bsky.social #Salamanca Symposium.
See you there!
#senescence #EarlyCareerResearchers
🚀 PhD Opportunity in the NUCLEAR Doctoral Network!
🎓 Eligibility: Applicants must meet the MSCA mobility rule.
📩 Deadline 11 Dec. Apply here:
lnkd.in/eKM8JKeE
🔗 Learn more about our lab: www.rodriguezcolmanlab.org
Please share within your networks! 🌍🧬
We appoint researchers from across biology and biomedicine to set up their first groups at the Crick.
📢 Last chance to join the NUCLEAR project!
Eisbach Bio GmbH is seeking a motivated PhD student to study NAD+ modulation of PARP1/2 in cancer research.
Deadline application: November 27.
Apply here: www.eisbach.bio#175327907442...
James Briscoe
🚨 SAVE THE DATE – Young ICSA Symposia 2026
For the first time, we will host meetings in US and Spain for early-career researchers in cellular senescence.
📅 May 11 – yICSA Symposium, Mayo Clinic (Rochester, MN)
📅 Sept 15–16 – yICSA Salamanca (CIC), ahead of @senescel.org
More info coming soon!
NUCLEAR-DN
The @crick.ac.uk is recruiting Early Career Group Leaders
- Lab set-up, research costs, salaries for up to 5 researchers
- Support for up to 12 years
- Access to our core facilities
- Competitive salary
- Fantastic colleagues
- All areas of biology
Deadline 27 Nov
www.crick.ac.uk/careers-stud...
James Briscoe
We appoint researchers from across biology and biomedicine to set up their first groups at the Crick.
